Social Capital Suvretta Holdings Corp. III Announces Pricing of Upsized $220,000,000 Initial Public Offering
Social Capital Suvretta Holdings Corp. III has priced its upsized initial public offering (IPO) at $10.00 per share for 22,000,000 Class A ordinary shares, set to trade under the ticker symbol DNAC starting June 30, 2021. The company focuses on mergers in the biotechnology sector, particularly in the organ space subsector. Morgan Stanley acts as the sole book-running manager, with an option for underwriters to purchase an additional 3,300,000 shares. Registration statements became effective June 29, 2021, with detailed offerings available via the SEC.
- The IPO of 22,000,000 Class A ordinary shares at $10.00 each indicates strong demand.
- The focused strategy on the biotechnology industry can lead to significant growth opportunities.
- A 45-day option for underwriters to purchase additional shares could bolster initial capital raised.
- No guarantees exist that the offering will be completed as planned or that net proceeds will be used as indicated.
Social Capital Suvretta Holdings Corp. III (the "Company") announced today that it has priced its upsized initial public offering of 22,000,000 Class A ordinary shares at
The Company is led by Chamath Palihapitiya and Kishen Mehta and is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on businesses operating in the biotechnology industry and within the organ space subsector.
Morgan Stanley is acting as sole book-running manager, and SoFi is acting as co-manager. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,300,000 Class A ordinary shares at the initial public offering price to cover over-allotments, if any.
The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained for free from the U.S. Securities and Exchange Commission (the "SEC") website http://www.sec.gov; or from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, Email: prospectus@morganstanley.com.
Registration statements relating to the securities became effective on June 29, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Forward-Looking Statements
This press release contains statements that constitute "forward-looking statements," including with respect to the proposed initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's preliminary prospectus for the Company's offering filed with the SEC. Copies of these documents are available on the SEC's website, http://www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210630005606/en/
FAQ
What are the details of the DNAC IPO?
When will DNAC shares begin trading?
What is the focus of Social Capital Suvretta Holdings Corp. III?
Who is managing the DNAC IPO?
